Paper36964277
Characterization of purinergic signaling in tumor-infiltrating lymphocytes from lower- and high-grade gliomas.
Scholl JN and 12 others. Purinergic Signal, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Characterization of purinergic signaling in tumor-infiltrating lymphocytes from lower- and high-grade gliomas. Papers, record 36964277. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36964277
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Characterization of purinergic signaling in tumor-infiltrating lymphocytes from lower- and high-grade gliomas.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| Glioma | Major topic |
| Humans | |
| Lymphocytes, Tumor-Infiltrating | |
| Isocitrate Dehydrogenase | |
| Prognosis | |
| Mutation | |
| Tumor Microenvironment |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| nº 140977/2019-8 | Conselho Nacional de Desenvolvimento Científico e Tecnológico | PubMed | ||
| n° 406035/2021-0 | Conselho Nacional de Desenvolvimento Científico e Tecnológico | PubMed | ||
| 465671/2014-4 | Instituto Nacional de Ciência e Tecnologia | PubMed | ||
| 21/2551-0001972-7 | Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul | PubMed |
Source PubMed
References89
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20800066 | Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation. | J Immunol Methods | 2010 | https://conductscience.org/library/papers/20800066 | PubMed |
| 2 | 29603313 | CD38 protein deficiency induces autoimmune characteristics and its activation enhances IL-10 production by regulatory B cells. | Scand J Immunol | 2018 | https://conductscience.org/library/papers/29603313 | PubMed |
| 3 | 24464643 | NTPDase3 and ecto-5'-nucleotidase/CD73 are differentially expressed during mouse bladder cancer progression. | Purinergic Signal | 2014 | https://conductscience.org/library/papers/24464643 | PubMed |
| 4 | 34185076 | The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. | Neuro Oncol | 2021 | https://conductscience.org/library/papers/34185076 | PubMed |
| 5 | 29066514 | CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8+ T Cells. | Cancer Res | 2018 | https://conductscience.org/library/papers/29066514 | PubMed |
| 6 | 17932254 | The genomic landscapes of human breast and colorectal cancers. | Science | 2007 | https://conductscience.org/library/papers/17932254 | PubMed |
| 7 | 27236363 | Regulation of the T Cell Response by CD39. | Trends Immunol | 2016 | https://conductscience.org/library/papers/27236363 | PubMed |
| 8 | 29769722 | Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates. | Nature | 2018 | https://conductscience.org/library/papers/29769722 | PubMed |
| 9 | 32425977 | CD38 Predicts Favorable Prognosis by Enhancing Immune Infiltration and Antitumor Immunity in the Epithelial Ovarian Cancer Microenvironment. | Front Genet | 2020 | https://conductscience.org/library/papers/32425977 | PubMed |
| 10 | 27321181 | Extracellular purines, purinergic receptors and tumor growth. | Oncogene | 2017 | https://conductscience.org/library/papers/27321181 | PubMed |
| 11 | 32471032 | Transcriptional Activity and Stability of CD39+CD103+CD8+ T Cells in Human High-Grade Endometrial Cancer. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32471032 | PubMed |
| 12 | 18636315 | The role of ecto-5'-nucleotidase/CD73 in glioma cell line proliferation. | Mol Cell Biochem | 2008 | https://conductscience.org/library/papers/18636315 | PubMed |
| 13 | 17449799 | Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. | Blood | 2007 | https://conductscience.org/library/papers/17449799 | PubMed |
| 14 | 34085407 | Prognostic importance of IDH mutations in chondrosarcoma: An individual patient data meta-analysis. | Cancer Med | 2021 | https://conductscience.org/library/papers/34085407 | PubMed |
| 15 | 32721947 | Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration. | JCI Insight | 2020 | https://conductscience.org/library/papers/32721947 | PubMed |
| 16 | 28407145 | GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. | Nucleic Acids Res | 2017 | https://conductscience.org/library/papers/28407145 | PubMed |
| 17 | 23576305 | CD38 and CD157: a long journey from activation markers to multifunctional molecules. | Cytometry B Clin Cytom | 2013 | https://conductscience.org/library/papers/23576305 | PubMed |
| 18 | 29348577 | Targeting B cell receptor signalling in cancer: preclinical and clinical advances. | Nat Rev Cancer | 2018 | https://conductscience.org/library/papers/29348577 | PubMed |
| 19 | 28249894 | Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Mitigate Immunosuppression in Multiple Myeloma. | Clin Cancer Res | 2017 | https://conductscience.org/library/papers/28249894 | PubMed |
| 20 | 17502665 | Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. | J Exp Med | 2007 | https://conductscience.org/library/papers/17502665 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41893304 | Integrating Transcriptomics and 3D Spheroid Models Reveals Microenvironment-Dependent Purinergic Modulation in Hepatocellular Carcinoma. | Metabolites | 2026 | https://conductscience.org/library/papers/41893304 | PubMed |
| 41250961 | Cellular Morphometric Analysis (CellMorph)-a comprehensive imaging-based tool for quantifying cellular phenotype heterogeneity and dynamics across biological processes. | FEBS J | 2026 | https://conductscience.org/library/papers/41250961 | PubMed |
| 41105161 | T cell immunity in glioma and potential implications for immunotherapy: A systematic review. | Neuro Oncol | 2026 | https://conductscience.org/library/papers/41105161 | PubMed |
| 40806376 | Non-Canonical Functions of Adenosine Receptors: Emerging Roles in Metabolism, Immunometabolism, and Epigenetic Regulation. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806376 | PubMed |
| 40366422 | Assessing Ecto-5'-Nucleotidase/CD73 Expression and Malignancy Parameters in Early- and Late- Passage C6 Glioma Cells. | Neurochem Res | 2025 | https://conductscience.org/library/papers/40366422 | PubMed |
| 40143161 | Glioblastoma Tumor Microenvironment and Purinergic Signaling: Implications for Novel Therapies. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40143161 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IDH1 | 3417 | PubTator's text mining | https://conductscience.org/library/genes/3417 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36964277
GET https://conductscience.org/api/papers/v1/36964277/references?page=2